BALTIMORE--(BUSINESS WIRE)--Cerecor Inc. (NASDAQ: CERCU), a clinical-stage biopharmaceutical company with the goal of becoming a leader in the development of innovative drugs that make a difference in the lives of patients with neurological and psychiatric disorders, today announced that the units issued in Cerecor’s recent initial public offering will separate on November 13, 2015. Each unit consists of one share of common stock of Cerecor, one Class A warrant to purchase one additional share of common stock of Cerecor and one Class B warrant to purchase one-half additional share of common stock of Cerecor.
Help employers find you! Check out all the jobs and post your resume.
